Crescent Capital BDC (NASDAQ:CCAP) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.55 earnings per share for the quarter, missing the consensus estimate of $0.56 by ($0.01), Zacks reports. Crescent Capital BDC had a return on equity of 12.20% and a net margin of 47.06%.

Crescent Capital BDC Price Performance

Shares of NASDAQ:CCAP remained flat at $20.00 during midday trading on Wednesday. 145,729 shares of the company traded hands, compared to its average volume of 86,199. Crescent Capital BDC has a twelve month low of $16.18 and a twelve month high of $20.19. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14. The business has a 50 day moving average of $19.47 and a 200-day moving average of $18.85. The firm has a market capitalization of $741.20 million, a P/E ratio of 7.84 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st were paid a $0.42 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. This represents a $1.68 annualized dividend and a dividend yield of 8.40%. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 65.88%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company raised their price target on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 29th. Keefe, Bruyette & Woods raised their price target on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Monday, November 25th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, Crescent Capital BDC has an average rating of “Moderate Buy” and a consensus price target of $19.33.

Check Out Our Latest Research Report on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Read More

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.